Tomoyuki Igawa

3.7k total citations
42 papers, 1.8k citations indexed

About

Tomoyuki Igawa is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Tomoyuki Igawa has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Immunology. Recurrent topics in Tomoyuki Igawa's work include Monoclonal and Polyclonal Antibodies Research (32 papers), Protein purification and stability (19 papers) and Glycosylation and Glycoproteins Research (16 papers). Tomoyuki Igawa is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (32 papers), Protein purification and stability (19 papers) and Glycosylation and Glycoproteins Research (16 papers). Tomoyuki Igawa collaborates with scholars based in United States, Japan and Singapore. Tomoyuki Igawa's co-authors include Kunihiro Hattori, Kenta Haraya, Hiroyuki Tsunoda, Futa Mimoto, Tatsuhiko Tachibana, Taichi Kuramochi, Takehisa Kitazawa, Zenjiro Sampei, Tetsuhiro Soeda and Shinya Ishii and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Tomoyuki Igawa

42 papers receiving 1.6k citations

Peers

Tomoyuki Igawa
Sandra Verploegen Netherlands
Gregory L. Moore United States
Paul Sakorafas United States
Paul Balderes United States
Joyce Meesters Netherlands
Paul V. Beum United States
Kevin C. Lindquist United States
Ezogelin Oflazoglu United States
Jun-Ping Wei United States
Sandra Verploegen Netherlands
Tomoyuki Igawa
Citations per year, relative to Tomoyuki Igawa Tomoyuki Igawa (= 1×) peers Sandra Verploegen

Countries citing papers authored by Tomoyuki Igawa

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Igawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Igawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Igawa more than expected).

Fields of papers citing papers by Tomoyuki Igawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Igawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Igawa. The network helps show where Tomoyuki Igawa may publish in the future.

Co-authorship network of co-authors of Tomoyuki Igawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Igawa. A scholar is included among the top collaborators of Tomoyuki Igawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Igawa. Tomoyuki Igawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shao‐Cong, Hiroki Kawauchi, Yoko Kayukawa, et al.. (2024). 773 SOF10, selectively blocking latent TGF-β1 activation, potentiates the efficacy of checkpoint blockade therapy by modulating CAF dynamics and T cell infiltration. Regular and Young Investigator Award Abstracts. A877–A877. 1 indexed citations
2.
Sampei, Zenjiro, Christine X. Koo, Ying Xiu Toh, et al.. (2023). Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies. 12(2). 36–36. 3 indexed citations
3.
Chen, Chen, Tetsuya Wakabayashi, Masaru Muraoka, et al.. (2019). Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency. mAbs. 11(4). 632–638. 17 indexed citations
4.
Kuramochi, Taichi, Tomoyuki Igawa, Hiroyuki Tsunoda, & Kunihiro Hattori. (2018). Humanization and Simultaneous Optimization of Monoclonal Antibody. Methods in molecular biology. 213–230. 15 indexed citations
5.
Sampei, Zenjiro, Kenta Haraya, Tatsuhiko Tachibana, et al.. (2018). Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody. PLoS ONE. 13(12). e0209509–e0209509. 40 indexed citations
6.
Haraya, Kenta, Tatsuhiko Tachibana, & Tomoyuki Igawa. (2018). Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering. Drug Metabolism and Pharmacokinetics. 34(1). 25–41. 25 indexed citations
7.
Shiraiwa, Hirotake, Atsushi Narita, Mika Kamata‐Sakurai, et al.. (2018). Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974. Methods. 154. 10–20. 42 indexed citations
8.
Kitazawa, Takehisa, Keiko Esaki, Tatsuhiko Tachibana, et al.. (2017). Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens. Thrombosis and Haemostasis. 117(7). 1348–1357. 152 indexed citations
9.
Haraya, Kenta, Tatsuhiko Tachibana, Yuki Iwayanagi, et al.. (2016). PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody–antigen binding model. Drug Metabolism and Pharmacokinetics. 31(2). 123–132. 11 indexed citations
10.
Mimoto, Futa, Taichi Kuramochi, Hitoshi Katada, Tomoyuki Igawa, & Kunihiro Hattori. (2016). Fc Engineering to Improve the Function of Therapeutic Antibodies. Current Pharmaceutical Biotechnology. 17(15). 1298–1314. 12 indexed citations
11.
Ishii, Shinya, Shojiro Kadono, Yuki Iwayanagi, et al.. (2015). Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation. mAbs. 8(1). 65–73. 23 indexed citations
12.
Igawa, Tomoyuki, Futa Mimoto, & Kunihiro Hattori. (2014). pH-dependent antigen-binding antibodies as a novel therapeutic modality. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(11). 1943–1950. 53 indexed citations
13.
Mimoto, Futa, Hitoshi Katada, Shojiro Kadono, et al.. (2013). Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIaR131 and FcγRIIaH131. Protein Engineering Design and Selection. 26(10). 589–598. 101 indexed citations
14.
Mimoto, Futa, et al.. (2013). Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs. Molecular Immunology. 58(1). 132–138. 22 indexed citations
15.
Yoshihashi, Kazutaka, Minako Takeda, Takehisa Kitazawa, et al.. (2013). Anti‐factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation. Journal of Thrombosis and Haemostasis. 12(2). 206–213. 114 indexed citations
16.
Mimoto, Futa, Tomoyuki Igawa, Taichi Kuramochi, et al.. (2013). Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant. mAbs. 5(2). 229–236. 59 indexed citations
17.
Igawa, Tomoyuki, Atsuhiko Maeda, Kenta Haraya, et al.. (2013). Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo. PLoS ONE. 8(5). e63236–e63236. 75 indexed citations
18.
Kuramochi, Taichi, Tomoyuki Igawa, Hiroyuki Tsunoda, & Kunihiro Hattori. (2013). Humanization and Simultaneous Optimization of Monoclonal Antibody. Methods in molecular biology. 1060. 123–137. 29 indexed citations
19.
Igawa, Tomoyuki, Jun Sumaoka, & Masaharu Komiyama. (2000). Kinetic Studies on CE(IV)-Induced Hydrolysis of Single-Stranded and Double-Stranded Oligonucleotides. Nucleosides Nucleotides & Nucleic Acids. 19(5-6). 891–902. 2 indexed citations
20.
Igawa, Tomoyuki, Jun Sumaoka, & Makoto Komiyama. (1999). Improvement of efficiency of the Ce(IV)-induced DNA scission -- Relationship between the kinetic parameters (kcat and Km) and the DNA structure-. Nucleic Acids Symposium Series. 42(1). 231–232. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026